Search research articles
Contact Us
Filters
Showing results (161-170 of 220) with videos related to
Page
of 22
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 5, 2025
The history of Down syndrome-associated Alzheimer's disease; past, present, and future
Lucia Maure-Blesa, María Carmona-Iragui, Ira Lott, et al.
The Journal of Prevention of Alzheimer'S Disease
|
September 13, 2020
Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD)
S Walter, T B Clanton, O G Langford, et al.
JAMA Neurology
|
June 23, 2020
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial
Suzanne Craft, Rema Raman, Tiffany W Chow, et al.
Journal of Neurodevelopmental Disorders
|
March 24, 2022
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
Nicole T Baumer, Mara L Becker, George T Capone, et al.
Blood
|
July 10, 1998
Evidence for circulating bone marrow-derived endothelial cells
Q Shi, S Rafii, M H Wu, et al.
Frontiers in Neurology
|
September 27, 2021
Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
Jonathan D Santoro, Sarah Lee, Anthony C Wang, et al.
Leukemia
|
March 21, 2003
Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity
Z Zhu, K Hattori, H Zhang, et al.
Nature Medicine
|
October 16, 2025
MRI-based multi-organ clocks for healthy aging and disease assessment
, Huizi Cao, Zhiyuan Song, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 7, 2025
Brain cholinergic terminal density utilizing [<sup>18</sup>F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performance
Jason K Russell, Alexander C Conley, Brian D Boyd, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 24, 2017
Dissociation of Down syndrome and Alzheimer's disease effects with imaging
Dawn C Matthews, Ana S Lukic, Randolph D Andrews, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 220) with videos related to
Sort By:
Page
of 22
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 5, 2025
The history of Down syndrome-associated Alzheimer's disease; past, present, and future
Lucia Maure-Blesa, María Carmona-Iragui, Ira Lott, et al.
The Journal of Prevention of Alzheimer'S Disease
|
September 13, 2020
Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD)
S Walter, T B Clanton, O G Langford, et al.
JAMA Neurology
|
June 23, 2020
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial
Suzanne Craft, Rema Raman, Tiffany W Chow, et al.
Journal of Neurodevelopmental Disorders
|
March 24, 2022
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group
Nicole T Baumer, Mara L Becker, George T Capone, et al.
Blood
|
July 10, 1998
Evidence for circulating bone marrow-derived endothelial cells
Q Shi, S Rafii, M H Wu, et al.
Frontiers in Neurology
|
September 27, 2021
Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
Jonathan D Santoro, Sarah Lee, Anthony C Wang, et al.
Leukemia
|
March 21, 2003
Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity
Z Zhu, K Hattori, H Zhang, et al.
Nature Medicine
|
October 16, 2025
MRI-based multi-organ clocks for healthy aging and disease assessment
, Huizi Cao, Zhiyuan Song, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 7, 2025
Brain cholinergic terminal density utilizing [<sup>18</sup>F]-fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performance
Jason K Russell, Alexander C Conley, Brian D Boyd, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 24, 2017
Dissociation of Down syndrome and Alzheimer's disease effects with imaging
Dawn C Matthews, Ana S Lukic, Randolph D Andrews, et al.
Page
of 22